Accelerating Science: How to cure the incurable with cell and gene therapy

Application Note: Cancer Immunotherapy: Agilent xCELLigence RTCA handbook
22 November 2023

In this handbook, Agilent Technologies provides insights into cancer immunotherapy, exploring the strategies employed to harness the immune system for tumor targeting. The guide introduces Agilent xCELLigence real-time cell analysis (RTCA) and its diverse applications in cancer immunotherapy. It details how the xCELLigence RTCA assay works, covering the measurement of cellular impedance with E-Plates and explaining real-time cellular impedance traces.